IVERIC bio Inc. (ISEE)
IVERIC bio Statistics
Share Statistics
IVERIC bio has 137.98M shares outstanding. The number of shares has increased by 0% in one year.
| 137.98M |
| 0% |
| 0% |
| n/a |
| n/a |
| 642 |
| 0.01% |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is -14.75 and the forward PE ratio is null. IVERIC bio's PEG ratio is -0.5.
| -14.75 |
| n/a |
| 0 |
| n/a |
| 4.85 |
| -15.75 |
| -0.5 |
Enterprise Valuation
IVERIC bio has an Enterprise Value (EV) of 2.21B.
| 0 |
| -11.51 |
| -13.51 |
| -13.45 |
Financial Position
The company has a current ratio of 18.63, with a Debt / Equity ratio of 0.18.
| 18.63 |
| 18.63 |
| 0.18 |
| -0.51 |
| -0.59 |
| -83.88 |
Financial Efficiency
Return on Equity is -32.86% and Return on Invested Capital is -28.49%.
| -32.86% |
| -26.36% |
| -28.49% |
| n/a |
| $-1,078,190.18 |
| 163 |
| 0 |
| n/a |
Taxes
| -9.47M |
| 5.11% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 1.1, so IVERIC bio's price volatility has been higher than the market average.
| 1.1 |
| n/a |
| 38.02 |
| 26.09 |
| 69.05 |
| 4,945,949 |
Balance Sheet
The company has 476.3M in cash and 97.77M in debt, giving a net cash position of 378.54M.
| 476.3M |
| 97.77M |
| 378.54M |
| -864.81M |
| 613.41M |
| 572.17M |
Cash Flow
In the last 12 months, operating cash flow was -163.77M and capital expenditures -736K, giving a free cash flow of -164.51M.
| -163.77M |
| -736K |
| -164.51M |
| -1.36 |
Margins
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Dividends & Yields
ISEE does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| -6.78% |
| -6.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 22 |
| 1 |